8-K

Company

NovoCure Ltd

Filed

February 5, 2026

Period of Report

January 30, 2026

Accession Number

0001645113-26-000007

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →